Squarepoint Ops LLC Trims Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Squarepoint Ops LLC lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 49.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,675 shares of the company's stock after selling 13,640 shares during the period. Squarepoint Ops LLC's holdings in Ryan Specialty were worth $877,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Two Sigma Advisers LP grew its stake in shares of Ryan Specialty by 693.3% during the 4th quarter. Two Sigma Advisers LP now owns 35,700 shares of the company's stock worth $2,291,000 after purchasing an additional 31,200 shares during the period. Two Sigma Investments LP boosted its holdings in Ryan Specialty by 114.9% during the fourth quarter. Two Sigma Investments LP now owns 204,817 shares of the company's stock worth $13,141,000 after buying an additional 109,522 shares in the last quarter. ProShare Advisors LLC grew its position in Ryan Specialty by 11.6% during the fourth quarter. ProShare Advisors LLC now owns 4,979 shares of the company's stock valued at $319,000 after buying an additional 519 shares during the period. Quantinno Capital Management LP increased its holdings in Ryan Specialty by 5.9% in the fourth quarter. Quantinno Capital Management LP now owns 14,163 shares of the company's stock valued at $909,000 after buying an additional 783 shares in the last quarter. Finally, Nomura Holdings Inc. purchased a new position in Ryan Specialty in the fourth quarter valued at $906,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Price Performance

RYAN traded down $0.82 during trading on Tuesday, reaching $71.15. The company's stock had a trading volume of 802,624 shares, compared to its average volume of 985,597. The company has a market cap of $18.67 billion, a price-to-earnings ratio of 103.12, a PEG ratio of 1.19 and a beta of 0.68. The firm has a fifty day simple moving average of $69.91 and a two-hundred day simple moving average of $68.72. Ryan Specialty Holdings, Inc. has a 1 year low of $52.34 and a 1 year high of $77.16. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm's revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.35 earnings per share. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were issued a dividend of $0.12 per share. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 annualized dividend and a dividend yield of 0.67%. Ryan Specialty's dividend payout ratio is presently 141.18%.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of analyst reports. UBS Group raised their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Barclays dropped their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Morgan Stanley upped their target price on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. TD Cowen initiated coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Finally, Wells Fargo & Company cut their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.58.

Insider Activity

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 52.21% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.